Company Of The Day: Proctor & Gamble
Proctor & Gamble (NYSE:PG) posted a stronger than expected set of Q1 2022 results. While revenue grew by 7% year-over-year to $19.4 billion, adjusted earnings per share rose 6% to $1.33. However, gross margins declined by 400 basis points versus Q1 2021 to 46.7%.
- Should You Buy Colgate-Palmolive Stock At $80?
- Here’s A Better Pick Over Procter & Gamble Stock
- Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?
- This Pharmaceuticals Company Looks To Be A Better Pick Over Procter & Gamble Stock
- Consistent Sales Growth Has Helped Procter & Gamble Stock To Match The Market Returns
- Procter & Gamble Stock Has Outperformed The S&P 500 Since 2017 End: Here’s Why
While revenue growth was driven by the company’s healthcare and fabric & home care segments, P&G’s margins are being impacted by rising inflation and higher commodity costs.
P&G stock was up by 2.5% in Wednesday’s trading.
See Our Complete Analysis For Proctor & Gamble
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
|S&P 500 Return||-2%||-6%||99%|
|Trefis Multi-Strategy Portfolio||-2%||-9%||257%|
 Month-to-date and year-to-date as of 4/21/2022
 Cumulative total returns since the end of 2016
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates